If you live in Marietta and want to know whether adipose tissue banking is available to you, the answer is yes. The harder question is who gets regulated, and how. Georgia’s stem cell law took effect on July 1, 2026, and it changed what local clinicians must tell you first. It approved no therapy.
TLDR Marietta sits in Cobb County, about 15 miles northwest of Atlanta. Georgia House Bill 1275, cited as HB 1275 (2026 Ga. Laws Act 453), took effect July 1, 2026. It sets consent, advertising, and sourcing rules for licensed clinicians. It does not approve any therapy. Adipose tissue and everything derived from it remain investigational and not FDA approved, and banking guarantees no future eligibility, access, or benefit.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. No adipose-derived product currently has FDA approval for any disease, and House Bill 1275 did not change that. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.
Marietta sits in Cobb County, about 15 miles northwest of Atlanta in a straight line, inside the Atlanta-Sandy Springs-Roswell metro area. Census QuickFacts put the city’s population at 63,574 as of July 1, 2025.
Two rulebooks apply. Federal rules under 21 CFR Part 1271 govern human cells and tissues in all 50 states. House Bill 1275 is the new state layer, and it regulates licensed clinicians, not tissue banks and not patients. Save My Fat is a connector that links patients and providers with a U.S. tissue bank. It does not collect, process, store, or treat tissue.
Is Adipose Tissue Banking Legal for Marietta Residents?
Yes. Nothing in state or federal law stops a Georgia resident from having their own adipose tissue collected by a licensed clinician and preserved. Legal storage and approved use are separate questions.
Federal rules place human cells and tissues under 21 CFR Part 1271, and FDA treats adipose as a structural tissue. Because the tissue is your own, the autologous exception removes donor screening and testing. It removes nothing else. Registration, listing, good tissue practice, and labeling still apply, and tissue held for your own use must be labeled FOR AUTOLOGOUS USE ONLY.
Georgia adds a layer. It has no standalone tissue bank statute, so tissue banks sit inside the Georgia laboratory rules for clinical laboratories, where tissue banking is its own licensure category. Adipose tissue is not named in those rules.
What Georgia House Bill 1275 Requires of Local Providers
HB 1275 (2026 Ga. Laws Act 453) was signed in May 2026 and took effect July 1, 2026. It requires three things of a physician, or of a physician assistant or nurse practitioner acting on lawful designation: signed consent, an advertising notice, and cells from a qualifying facility. The enrolled bill text is public.
Consent must be signed before the therapy, in a language the patient may reasonably be expected to understand. It covers the nature and character of the proposed treatment, the fact that the therapy has not yet been approved by the FDA, and the anticipated results.
The notice must appear in any form of advertisement, in type no smaller than the largest type used for the services offered. It states that the physician or designee “performs one or more human stem cell therapies that have not yet been approved by the FDA.”
Cells must come from a facility registered with the FDA and located in Georgia, another state, or another country, or one certified and accredited by the World Marrow Donor Association, the Association for the Advancement of Blood and Biotherapies, the American Association of Tissue Banks, or another entity the Department of Public Health deems appropriate. A violation may bring discipline from the licensee’s professional board, and nothing more.
Four Things House Bill 1275 Does Not Do
The law is narrower than the headlines suggest, and our Georgia stem cell law breakdown goes deeper. First, it does not legalize, authorize, approve, or create access to any stem cell therapy. No patient entitlement language appears in the text.
Second, it does not require the facility to sit in Georgia. The introduced bill said Georgia; the enacted text says Georgia, another state, or another country. Third, it does not impose a minimal manipulation standard. That term is defined and then never used again in the operative text. Fourth, the National Marrow Donor Program is not an accepted accreditor. It was removed before passage.
How a Marietta Patient Starts, and What It Costs
It starts with a licensed physician, because collecting adipose tissue is a medical procedure. A plain overview of how banking works covers the sequence in order.
On cost, be skeptical of numbers you see elsewhere. There is no authoritative public dataset on adipose tissue banking cost in the United States, so nothing qualifies as an industry benchmark. Save My Fat publishes its own figures on its pricing page.
Adipose tissue and everything derived from it is investigational and not FDA approved for any disease, and the science is early. FDA says so in its consumer alert on regenerative medicine products. Talk with your own licensed provider before deciding anything.
Frequently Asked Questions
Does banking require a referral from a local physician?
No referral to a therapy is involved, because banking is not a therapy. A licensed clinician does have to perform the collection, since removing adipose tissue is a medical procedure. Ask your own physician first.
Do I have to use a facility located in Georgia?
No. Under HB 1275, cells may be retrieved, manufactured, and stored in a facility registered with the FDA and located in Georgia, another state in the United States, or another country. The bill’s caption still reads otherwise. The operative text controls.
Is adipose tissue banking the same as a stem cell therapy?
No. Banking preserves your own tissue and nothing more. It does not guarantee eligibility, access, or clinical benefit from any future therapy, trial, or program. No adipose-derived product appears on FDA’s roster of approved cell therapies.
Key Takeaways
Marietta residents can have their own adipose tissue collected and preserved, and Georgia law does not stand in the way. What the state did in 2026 was tighten the rules on licensed clinicians: signed consent, an advertising notice, and a sourcing standard, backed by professional board discipline and nothing else. It approved no therapy and created no right to one. Federal rules under 21 CFR Part 1271 still govern the tissue. Any future use depends on FDA regulatory status, physician guidance, and the pathways that exist then.
Save My Fat operates as a tissue preservation service, not a medical practice or treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, California, Georgia, and Tennessee governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.
Readers weighing adipose tissue banking for potential future use can review current pricing or start a conversation through the contact page.
Save My Fat works with a U.S.-based tissue bank for laboratory processing and storage.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including neurology and neurosurgery input is required before publication. Please consult your neurologist or neurosurgeon before making any decisions about adipose tissue banking or research participation.
About the author: Oscar Tellez is the founder and CEO of Save My Fat. He holds a Bachelor of Science in Exercise Science and Health Promotion from Florida Atlantic University. He has spent more than a decade in the regenerative medicine industry across product distribution, laboratory and vendor relationships, and provider training. He is not a licensed clinician, and this article is educational, not medical advice.
Related guide: state stem cell laws.
